TG Therapeutics stock skyrocketed Monday after easily beating fourth-quarter sales expectations and issuing a bullish outlook for 2025.
Behind declines for shares of NVIDIA Corp. and Amazon.com Inc., the Dow Jones Industrial Average is trading down Monday morning.